8/11/2021

Docusate Sodium Oral Liquid in Bulk Bottles

Products Affected - Description

- Diocto oral liquid, Geri-Care, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0403-16 - discontinued
- Diocto oral syrup, Geri-Care, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0409-16 - discontinued

Reason for the Shortage

- Akorn did not provide a reason for the shortage.
- Geri-Care had a contract manufacturer shut down. The company has discontinued Diocto syrup and liquid.
- Lannett has Silace available.
- Docusate sodium 10 mL unit dose cups are not affected.

Available Products

- Docu Liquid oral liquid, Akorn, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 50383-0771-16
- Silace oral liquid, Lannett, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0116-80
- Silace oral syrup, Lannett, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0107-80

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated August 11, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 19, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.